6PU-30739-64000
3 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 913 / CA
- Registered
- 2022-06-27
- Relationship
- Child or adolescent in my care
- Guardian
- W3X-29003-42534
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-27
Registered in v-safe
-
2022-07-18
Dose 1 — Pfizer-BioNTech
- 2022-08-01
-
2022-08-03
Dose 2 — Pfizer-BioNTech
- 2022-08-15
- 2022-08-17
- 2022-08-24
- 2022-08-31
-
2022-09-09
Survey response — day 35, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: She had a coldMedDRA releases: 2024-11 · check-in free text available
- 2022-09-14
-
2022-10-04
Dose 3 — Pfizer-BioNTech
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2023-01-03
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-18 | Pfizer-BioNTech | No |
| 2 | 2022-08-03 | Pfizer-BioNTech | No |
| 3 | 2022-10-04 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: She had a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release